Results 111 to 120 of about 27,891 (280)

Effects of montelukast on M2-related cytokine and chemokine in M2 macrophages

Journal of Microbiology, Immunology and Infection, 2018
Background/Purpose: Asthma is a chronic airway inflammatory disease mediated by T-helper (Th)2 cells. Montelukast (trade name Singulair) is a cysteinyl leukotriene receptor antagonist used for asthma treatment.
Yi-Ching Lin, Ming-Yii Huang, Min-Sheng Lee, Chong-Chao Hsieh, Hsuan-Fu Kuo, Chang-Hung Kuo, Chih-Hsing Hung   +6 more
doaj   +1 more source

Efecto del aceite esencial de Minthostachys verticillata sobre la respuesta inmune de pacientes alérgicos a ácaros del polvo [PDF]

, 2009
El aceite esencial de hojas de M. verticillata fue obtenido por destilación en corriente de vapor y analizado por cromatografía gaseosa. Células mononucleares de sangre periférica de pacientes alérgicos, fueron estimuladas con aceite esencial.
Andrada, Melisa, Cariddi, Laura Noelia, Demo, Mirta Susana, Maldonado, Ana Maria, Moser, Marina, Sabini, Liliana Ines, Zygadlo, Julio Alberto   +6 more
core  

Nasal lysine aspirin challenge in the diagnosis of aspirin - exacerbated respiratory disease [PDF]

, 2013
Background Aspirin-exacerbated respiratory disease is under-diagnosed and therefore effective and inexpensive therapy with aspirin desensitization is rarely performed.
Darby, Y, Gane, S, Larco, J, Miller, B, Mirakian, R, Sannah, AA, Scadding, G   +6 more
core   +1 more source

Parasomnias and sleep‐related movement disorders induced by drugs in the adult population: a review about iatrogenic medication effects

Journal of Sleep Research, Volume 34, Issue 2, April 2025.
Summary Parasomnias and sleep‐related movement disorders (SRMD) are major causes of sleep disorders and may be drug induced. The objective of this study was to conduct a systematic review of the literature to examine the association between drug use and the occurrence of parasomnias and SRMD.
Sylvain Dumont, Vanessa Bloch, Agnès Lillo‐Lelouet, Christine Le Beller, Pierre A. Geoffroy, Marc Veyrier   +5 more
wiley   +1 more source

Churg-Strauss syndrome with montelukast [PDF]

Thorax, 2001
The case report by Tuggey and Hosker1 is similar to many of the cases of Churg-Strauss syndrome (CSS) which we have reported in association with zafirlukast,2 montelukast, and fluticasone/salmeterol.3 It also shares many similarities with the reports of CSS with inhaled steroid monotherapy.4 5 While a temporal relationship with the use of leukotriene
openaire   +3 more sources

A possible effect of montelukast on neurological aging examined by the use of register data

International Journal of Clinical Pharmacy, 2020
Background The leukotriene receptor antagonist montelukast has been shown to rejuvenate aged brains in rats; however, data on humans are still scarce.
B. Grinde, H. Schirmer, A. Eggen, L. Aigner, B. Engdahl   +4 more
semanticscholar   +1 more source

Relationship Between Gender and the Effectiveness of Montelukast: An Italian/Danish Register-Based Retrospective Cohort Study

Frontiers in Pharmacology, 2018
Rationale: Gender-related differences in asthma prevalence, pathophysiology and clinical features induced by sex steroids have been investigated, however, how gender influences response to asthma treatments in routine clinical practice have not yet been ...
Maurizio Sessa, Maurizio Sessa, Annamaria Mascolo, Bruno D'Agostino, Antonio Casciotta, Vincenzo D'Agostino, Fausto De Michele, Mario Polverino, Giuseppe Spaziano, Mikkel Porsborg Andersen, Kristian Kragholm, Kristian Kragholm, Kristian Kragholm, Francesco Rossi, Christian Torp-Pedersen, Christian Torp-Pedersen, Annalisa Capuano   +16 more
doaj   +1 more source

Genetic basis for personalized medicine in asthma [PDF]

, 2012
There is heterogeneity in patient responses to current asthma medications. Significant progress has been made identifying genetic polymorphisms that influence the efficacy and potential for adverse effects to asthma drugs, including; β2-adrenergic ...
Asano, Barnes, Basu, Bleecker, Bleecker, Choudhry, Corren, Currie, Drazen, Drysdale, Duan, Duroudier, Ferreira, Finotto, Gaston, Gudbjartsson, Haldar, Hall, Hammad, Hawkins, Hawkins, Hayakawa, Himes, Holloway, Ian Sayers, Israel, Jin, Kang, Kearley, Kim, Klotsman, Koster, Lee, Lee, Lima, Lima, Litonjua, Liu, Maarsingh, Malmstrom, Mastalerz, Meurs, Michael Portelli, Moffatt, Moffatt, Moore, Mougey, Obeidat, Ober, Oshikawa, Panebra, Panebra, Pascual, Prefontaine, Reihsaus, Risma, Sampson, Savenije, Sayers, Sayers, Slager, Sleiman, Stevens, Tantisira, Tantisira, Tantisira, Tantisira, Torgerson, Trian, Tse, Vonk, Wechsler, Wenzel, Whalen, Whelan, Ye, York   +76 more
core   +2 more sources

Leukotrienes: Bridging the Inflammatory Gap in Asthma and Inflammatory Bowel Diseases (IBD)

Comprehensive Physiology, Volume 15, Issue 3, June 2025.
Dissecting the pathophysiological role of Leukotrienes in the lung–gut axis: A potential mediator of the asthma–IBD crosstalk. ABSTRACT Leukotrienes are potent inflammatory lipid mediators produced primarily by immune cells. Inflammation, being the center stone of two major disease conditions, namely, asthma and inflammatory bowel disease (IBD), has ...
Emma Elizabeth Sabu Kattuman, Lakshminarayan Reddy Teegala, Somayeh Darzi, Charles K. Thodeti, Sailaja Paruchuri   +4 more
wiley   +1 more source

Montelukast in the management of allergic rhinitis

Therapeutics and Clinical Risk Management, 2007
Allergic rhinitis is the most common atopic disorder seen in the outpatient clinic setting diagnosed by history, physical exam and objective testing. According to the Allergic Rhinitis and its Impact on Asthma (ARIA) document, it is classified by chronicity (intermittent or persistent), and severity which is based on symptoms and quality of life (mild,
Jaime A Lagos, Gailen D. Marshall
openaire   +3 more sources